Thu.Oct 10, 2024

article thumbnail

STAT+: Medical journal peer reviewers are paid millions by industry, study finds

STAT

Nearly 60% of the experts who reviewed manuscripts for four prominent medical journals received at least one payment from industry during a recent three-year period and, overall, these reviewers or their institutions received more than $1 billion from companies, according to a new analysis. Between 2020 and 2022, 1,155 of the 1,962 experts who reviewed studies for The BMJ, JAMA, The Lancet, and The New England Journal of Medicine received some form of payment.

article thumbnail

Johnson & Johnson myeloma drug recommended for NHS use

Pharma Times

Teclistamab offers hope for patients exhausting treatment options

151
151
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

STAT+: Frustrated telehealth providers say their businesses face ‘doom and gloom’

STAT

Telehealth providers treating opioid use disorder, ADHD, and women’s health issues say the sector is in a state of frustration and chaos as the pandemic-era flexibilities that allowed their businesses to thrive are set to end with no new rules in sight. With just months to go before the ability to prescribe controlled substances online dramatically changes overnight, the vacuum of information is forcing them to devote significant energy preparing for the unknown.

article thumbnail

Heart patient goes home hours after live-streamed valve replacement

Pharma Times

Sheffield cardiologists demonstrate cutting-edge TAVI procedure

145
145
article thumbnail

Navigating Payroll Compliance: Future-Proofing Payroll in an Evolving Regulatory Landscape

Speaker: Jennifer Hill

Payroll compliance is a cornerstone of business success, yet for small and midsize businesses, it’s becoming increasingly challenging to navigate the ever-evolving landscape of federal, state, and local regulations. Mistakes can lead to costly penalties and operational disruptions, making it essential to adopt advanced solutions that ensure accuracy and efficiency.

article thumbnail

Is the future of AI in health care just a lot of hype?

STAT

Amid excitement over everything from Chat-GPT to Nobel Prize-winning chemistry research that uses artificial intelligence to predict protein structures, academics Aravind Narayan and Sayash Kapoor have established a reputation for throwing cold water on at least some of the claims about how AI will transform people’s lives.  Narayan, a professor of computer science at Princeton University, went viral in 2019 for a talk he gave at MIT on how to recognize overblown declarations about A

More Trending

article thumbnail

Bill Nye, Science Guy, speaks out on ataxia

STAT

Bill Nye the Science Guy is temporarily rebranding. For now, he’s “ Bill Nye the Ataxia Advocate Guy ,” as he aims to bring awareness to a neurological disease that has affected his family for generations. Nye has previously spoken about the genetic disease, which makes it difficult for people with the condition to control their muscles and often leads to problems with walking and speech, in a documentary released in 2017.

339
339
article thumbnail

Regeneron takes the long-haul approach to oncology, stumbles and all

PharmaVoice

Although Regeneron has been playing catch-up in the oncology field for years, a pipeline built on next-wave promises could push the boundaries.

130
130
article thumbnail

Africa CDC faults U.S. government over Marburg-related travel advisory to Rwanda

STAT

The director general of the Africa Centres for Disease Control and Prevention and Rwanda’s health minister on Thursday criticized the U.S. government’s decision to urge Americans to avoid travel to Rwanda because of the country’s ongoing Marburg outbreak. Calling the travel alert a travel ban — it is not — Jean Kaseya, who heads the Africa CDC, suggested the U.S. action was counterproductive and unfair to a country that is being transparent about its efforts to

338
338
article thumbnail

Pharmacy First 'good starting point' for PA scope of practice, says RCGP

The Pharmacist

The clinical pathways delivered under Pharmacy First are a 'good starting point' to define the scope of practice for Physician Associates (PAs), the Royal College of GPs (RCGP) has said. Pharmacists must undertake additional training to deliver minor ailments consultations under Pharmacy First. But the RCGP suggested that 'first point of contact presentations' of over […] The post Pharmacy First 'good starting point' for PA scope of practice, says RCGP appeared first on The Pharm

124
124
article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

STAT+: Sarepta’s gene therapy is fully approved, but its stock has tanked. Here’s why

STAT

This story was first published in the online edition of Adam’s Biotech Scorecard, a subscriber-only newsletter. STAT+ subscribers can sign up  here  to get it delivered to their inbox. Sarepta Therapeutics CEO Doug Ingram is upset about the company’s slumping stock price.  Investors who have interacted with him this summer, including during a whitewater rafting trip, told me Ingram has been venting his frustration to anyone who will listen.

319
319
article thumbnail

Ex-Pfizer execs ‘threatened’ for supporting plans to shake up company, Starboard says

BioPharma Dive

In a letter to Pfizer’s board, the activist investor claimed former CEO Ian Read and CFO Frank D’Amelio were pressured to abandon a Starboard-led attempt to change the company’s direction.

120
120
article thumbnail

Opinion: My four kids and I all have ADHD. We need telehealth options

STAT

On Thursday, the CDC released new data showing that almost 15.5 million U.S. adults are living with ADHD. More than half of those individuals received their diagnosis in adulthood.   That includes me. The diagnosis came as a relief and validation — a way to understand years of impulsivity, inattention, and struggles with daily life. I was diagnosed at age 36, after first one, then two, and ultimately, four of my five children were also diagnosed with ADHD.

314
314
article thumbnail

Concern over ‘incorrect and misleading’ pharmacy figures

The Pharmacist

Concern has been raised over what have been described as 'incorrect and misleading' figures released today by the NHS Business Services Authority (NHSBSA) which suggest a record number of active dispensing contractors in several years. New data published by the NHSBSA claim that 2023/24 saw the 'highest number of active dispensing contractors since 2015/16'.

119
119
article thumbnail

Why Every Small Business Needs an HCM Solution: A Comprehensive Guide

Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.

article thumbnail

STAT+: Teva agrees to pay $450 million to settle kickback and price-fixing allegations

STAT

In the largest settlement of its kind, Teva Pharmaceuticals agreed to pay $425 million to resolve allegations the company and a related business paid kickbacks to charitable foundations in order to boost usage of a pricey medicine. Separately, the drugmaker agreed to pay $25 million to settle charges of participating in a price-fixing scheme with other generic companies.

article thumbnail

UK celeb seeks funds to challenge NICE's Enhertu verdict

pharmaphorum

Media personality Nadia Sawalha is heading a fundraising effort to launch an appeal against NICE's recent rejection of a breast cancer therapy Enhertu.

115
115
article thumbnail

Opinion: New mental health parity laws are already under threat

STAT

The ink had scarcely dried on  new federal rules  for enforcement of the Mental Health Parity and Addiction Equity Act of 2008 when U.S. health plans  threatened potential legal action  to block them.  Buoyed by a recent Supreme Court ruling that  shifts power away from federal agencies , health plans apparently hope to keep the departments of Labor, Treasury, and Health and Human Services from making parity a reality, years after Congress passed the law with r

287
287
article thumbnail

The Role of China in the Global Generic Drug API Market

Drug Patent Watch

China has emerged as a significant player in the global generic drug active pharmaceutical ingredient (API) market. The country’s vast production capacity, low costs, and strategic location have made it an attractive destination for pharmaceutical companies seeking to source APIs.

article thumbnail

Best Practices to Streamline Compensation Management: A Foundation for Growth

Speaker: Joe Sharpe and James Carlson

Payroll optimization can be one of the most time-consuming and complex factors of small business management. Yet, organizations that crack the code on streamlining employee compensation often discover innovative avenues for growth. With the right strategies in place, outsourcing and streamlining payroll processes can result in substantial time and resource savings.

article thumbnail

STAT+: Warren urges FTC to probe deal that would give Novo Nordisk control of some Catalent plants

STAT

U.S. Sen. Elizabeth Warren has asked the Federal Trade Commission “closely scrutinize” a $16.5 billion deal in which Novo Nordisk’s parent foundation would acquire Catalent, a leading contract drug manufacturer, over concerns the acquisition would give the pharmaceutical company an unfair advantage in the burgeoning market for drugs used to treat obesity and diabetes.

Packaging 287
article thumbnail

Community pharmacy repeat prescription review service ‘should be explored’

The Pharmacist

A commissioned 'repeat prescription review' service in community pharmacy should be explored to improve medicines adherence and patient understanding, the Royal Pharmaceutical Society (RPS) and Royal College of GPs (RCGP) have suggested. The recommendation comes as part of a new repeat prescribing toolkit, in what is believed to be the first guidance of its kind […] The post Community pharmacy repeat prescription review service ‘should be explored’ appeared first on The Pharmacist.

article thumbnail

STAT+: Amid a rough biotech job market, fewer biomedical Ph.D. grads head for industry, data show

STAT

Over the past decade, there has been a clear and unprecedented exodus of young life scientists from academia and into lucrative industry jobs. But new data provide evidence that this trend is slowing, at least for now. The latest numbers from the Survey of Earned Doctorates, an annual National Science Foundation census of freshly minted Ph.D. graduates, show that 61.6% of biomedical scientists who had a job lined up were bound for industry in 2023.

287
287
article thumbnail

Starboard claims Pfizer 'threatened' former leaders

pharmaphorum

Starboard Value alleges former Pfizer execs Ian Read and Frank D'Amelio were bullied into lending their support to current management

111
111
article thumbnail

Enhance Healthcare Efficiency With Top Payroll & HCM Services

Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.

article thumbnail

Crypto for CRISPR, a new RNAi startup, & a Nobel for AI

STAT

How does John Maraganore decide which startups to get involved in? Why are longevity-minded tech bros getting involved with a controversial CRISPR scientist? And who would you rather hang out with at the STAT Summit next week, Adam or Allison? We discuss all that and more on this week’s episode of “The Readout LOUD,” STAT’s biotech podcast.

287
287
article thumbnail

EVERSANA partners Oracle on pharmacovigilance platform

pharmaphorum

EVERSANA partners Oracle on pharmacovigilance platform Phil.

111
111
article thumbnail

A crack of light for Pfizer

STAT

This story first appeared in The Readout newsletter.  Sign up for The Readout  and receive STAT’s award-winning biotech news delivered straight to your inbox.  Morning. Today, we are sad to report that more children have developed blood cancers after receiving Bluebird Bio’s CALD gene therapy, Skysona. There’s a new twist in the Pfizer activist shareholder campaign.

article thumbnail

CPHI Milan 2024: What Does the Future Pharma Workforce Look Like?

PharmaTech

Five speakers discussed the impact of the COVID-19 pandemic, the rise of artificial intelligence, more women in leadership tracks in the industry, and various emerging technologies.

109
109
article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.